Issue 15, 2014

The first stereoselective total synthesis of a new antitumour and anti-inflammatory neolignan, surinamensinol A

Abstract

The stereoselective total synthesis of an antitumour and anti-inflammatory 8-O-4′-neolignan, surinamensinol A has been accomplished starting from two aldehydes, 3,4,5-trimethoxy benzaldehyde and vanillin. The key steps involve an asymmetric reduction using a chiral oxazaborolidine complex, a Sharpless asymmetric dihydroxyllation and a Mitsunobu reaction. This is the first report of the total synthesis of surinamensinol A.

Graphical abstract: The first stereoselective total synthesis of a new antitumour and anti-inflammatory neolignan, surinamensinol A

Supplementary files

Article information

Article type
Paper
Submitted
27 Sep 2013
Accepted
25 Nov 2013
First published
25 Nov 2013

RSC Adv., 2014,4, 7432-7434

The first stereoselective total synthesis of a new antitumour and anti-inflammatory neolignan, surinamensinol A

P. R. Reddy and B. Das, RSC Adv., 2014, 4, 7432 DOI: 10.1039/C3RA45419C

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements